Cargando…

ATP-responsive Mn(ii)-based T(1) contrast agent for MRI

A novel diacetylpyridylcarbohydrazide–DAPyCOHz-based manganese(ii) chelate with dipicolylamine/zinc(ii) (DPA/Zn(2+)) arms (MnL(DPA-Zn)2) was developed for adenosine triphosphate (ATP) responsive magnetic resonance imaging (MRI) T(1) contrast applications. Compound 2 shows enhanced relaxivity (r(1) =...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anbu, Sellamuthu, Kenning, Lawerence, Stasiuk, Graeme J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2023
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644988/ https://www.ncbi.nlm.nih.gov/pubmed/37902503 http://dx.doi.org/10.1039/d3cc03430e

Ejemplares similares

A Single‐Pot Template Reaction Towards a Manganese‐Based T (1) Contrast Agent
por: Anbu, Sellamuthu, et al.
Publicado: (2021)

Mn-Based MRI Contrast Agents: An Overview
por: Henoumont, Céline, et al.
Publicado: (2023)

An enzyme-activatable and cell-permeable Mn(III)-porphyrin as a highly efficient T(1) MRI contrast agent for cell labeling
por: Haedicke, Inga E., et al.
Publicado: (2016)

Mn(ii) chelate-coated superparamagnetic iron oxide nanocrystals as high-efficiency magnetic resonance imaging contrast agents
por: Wu, Changqiang, et al.
Publicado: (2020)

Cyclodextrins: promising scaffolds for MRI contrast agents
por: Sembo-Backonly, Berthe Sandra, et al.
Publicado: (2021)

Highly water-dispersible calcium lignosulfonate-capped MnO nanoparticles as a T(1) MRI contrast agent with exceptional colloidal stability, low toxicity and remarkable relaxivity
por: Arian, Mahdi, et al.
Publicado: (2019)

Fluorinated Eu(II)-based multimodal contrast agent for temperature- and redox-responsive magnetic resonance imaging
por: Basal, Lina A., et al.
Publicado: (2017)

Design of the elusive proteinaceous oxygen donor copper site suggests a promising future for copper for MRI contrast agents
por: Shah, Anokhi, et al.
Publicado: (2023)

Defining the conditions for the development of the emerging class of Fe(III)-based MRI contrast agents
por: Baranyai, Zsolt, et al.
Publicado: (2021)

A robust MRI contrast agent for specific display of the interstitial stream
por: Zhou, Xiaohan, et al.
Publicado: (2023)

New MRI contrast agents based on silicon nanotubes loaded with superparamagnetic iron oxide nanoparticles
por: Gonzalez-Rodriguez, Roberto, et al.
Publicado: (2018)

Systematic overview of soft materials as a novel frontier for MRI contrast agents
por: Gallo, Enrico, et al.
Publicado: (2020)

L-EGCG-Mn nanoparticles as a pH-sensitive MRI contrast agent
por: Li, Jiali, et al.
Publicado: (2020)

PEG-Coated MnZn Ferrite Nanoparticles with Hierarchical Structure as MRI Contrast Agent
por: Cheraghali, Sedigheh, et al.
Publicado: (2023)

Fe/Mn Multilayer Nanowires as High-Performance T(1)-T(2) Dual Modal MRI Contrast Agents
por: Cao, Xiaoming, et al.
Publicado: (2021)

Development of an MRI contrast agent for both detection and inhibition of the amyloid-β fibrillation process
por: Utomo, Rohmad Yudi, et al.
Publicado: (2022)

Fe(ii) and Mn(ii) removal by Ca(ii)–manganite (γ-MnOOH)-modified red mud granules in water
por: Su, Yingying, et al.
Publicado: (2019)

Polymeric Gd-DOTA amphiphiles form spherical and fibril-shaped nanoparticle MRI contrast agents
por: Randolph, Lyndsay M., et al.
Publicado: (2016)

Polymerizable Gd(iii) building blocks for the synthesis of high relaxivity macromolecular MRI contrast agents
por: Berki, Thomas R., et al.
Publicado: (2021)

Iron(iii) chelated paramagnetic polymeric nanoparticle formulation as a next-generation T(1)-weighted MRI contrast agent
por: Marasini, Ramesh, et al.
Publicado: (2021)

Monodisperse magnetic lecithin-PFP submicron bubbles as dual imaging contrast agents for ultrasound (US) and MRI
por: Waqar, Hira, et al.
Publicado: (2022)

A New Mixed-Valence Mn(II)Mn(III) Compound With Catalase and Superoxide Dismutase Activities
por: Costa, Rafael O., et al.
Publicado: (2018)

Paracetamol and other acetanilide analogs as inter-molecular hydrogen bonding assisted diamagnetic CEST MRI contrast agents
por: Chakraborty, Subhayan, et al.
Publicado: (2021)

Preparation and characterization of peptide modified ultrasmall superparamagnetic iron oxides used as tumor targeting MRI contrast agent
por: Yin, Jie, et al.
Publicado: (2019)

Magnetic interactions and in vitro study of biocompatible hydrocaffeic acid-stabilized Fe–Pt clusters as MRI contrast agents
por: Kostevšek, N., et al.
Publicado: (2018)

Fluorinated hydrogel nanoparticles with regulable fluorine contents and T(2) relaxation times as (19)F MRI contrast agents
por: Duan, Ziwei, et al.
Publicado: (2023)

Echogenic exosomes as ultrasound contrast agents
por: Osborn, Jenna, et al.
Publicado: (2020)

Porous MnFe(2)O(4)-decorated PB nanocomposites: a new theranostic agent for boosted T(1)/T(2) MRI-guided synergistic photothermal/magnetic hyperthermia
por: Zhou, Xi, et al.
Publicado: (2018)

A Photocleavable Contrast Agent for Light-Responsive MRI
por: Reeßing, Friederike, et al.
Publicado: (2020)

Contrast agents for hepatic MRI
por: Morana, Giovanni, et al.
Publicado: (2007)

MRI Contrast Agents in Glycobiology
por: Geraldes, Carlos F. G. C., et al.
Publicado: (2022)

MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue
por: Jynge, Per, et al.
Publicado: (2020)

AS1411 aptamer-modified theranostic liposomes co-encapsulating manganese oxide nano-contrast agent and paclitaxel for MRI and therapy of cancer
por: Li, Jingjing, et al.
Publicado: (2019)

Iron phosphide nanoparticles as a pH-responsive T(1) contrast agent for magnetic resonance tumor imaging
por: Qiu, Yuan, et al.
Publicado: (2019)

Preparation and MRI performance of a composite contrast agent based on palygorskite pores and channels binding effect to prolong the residence time of water molecules on gadolinium ions
por: Zhao, Minzhi, et al.
Publicado: (2022)

Quinone-fused porphyrins as contrast agents for photoacoustic imaging
por: Banala, Srinivas, et al.
Publicado: (2017)

Perfluorocarbon Emulsion Contrast Agents: A Mini Review
por: Holman, Ryan, et al.
Publicado: (2022)

MRI Contrast Agents for Pharmacological Research
por: Terreno, Enzo, et al.
Publicado: (2015)

Magnetic Nanomaterials as Contrast Agents for MRI
por: Caspani, Sofia, et al.
Publicado: (2020)

Magnetic Nanoparticles as MRI Contrast Agents
por: Avasthi, Ashish, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fp2elqig8vk2kh68unc4f7p6pq